bluebird bio Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : bluebird bio Inc.

BLUE 4.970

0.0%

Jun 2 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (1)	11/26/2013 11:19:27 AM
From: Biotech Jim	Read Replies (2) of 163

In performing due diligence on BLUE, I found it a little difficult to find the corporate presentation on its website. Of course the SEC filings are a bit easier to find. Here is the initial link to the presentations on the website, and also to find past presentations. bluebirdbio.com/investors & media/calendar of events/upcoming or past events As to the CAR T technology, I had asked IR if Carl June was a collaborator or an advisor. While providing other information, they did not answer the Dr. June question. I did not find his name mentioned in a couple of their SEC filings that I have viewed. The collaboration that BLUE has with CELG on the CAR T technology is with Baylor School of Medicine, specifically with the Center for Cell and Gene Therapy at Texas Children’s Hospital and The Methodist Hospital in Houston, led by Malcolm Brenner, M.D. Here is an older PR by BLUE on this collaboration. investor.bluebirdbio.com I am sure that both Rick and I will have more to say on CAR T technology and approaches in future posts.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next